An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity

An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity have?

An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity has 314 citations in the OpenAlex counts ScholarIQ stores.

When was An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity published?

An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity has 2011 year in the ScholarIQ index.

What is the open-access status of An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?

An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity has green oa status in the ScholarIQ index.

What is the DOI of An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?

The DOI for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is on the source record.

What is the PMID of An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?

The PMID for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is on the source record.

What is the OpenAlex record for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity?

The OpenAlex for An ALS-associated mutation affecting TDP-43 enhances protein aggregation, fibril formation and neurotoxicity is on the source record.